Jamie Dananberg - Aug 1, 2023 Form 4 Insider Report for Annexon, Inc. (ANNX)

Role
Chief Medical Officer
Signature
/s/ Jennifer Lew, as Attorney-in-Fact for Jamie Dananberg
Stock symbol
ANNX
Transactions as of
Aug 1, 2023
Transactions value $
$0
Form type
4
Date filed
8/2/2023, 05:07 PM
Previous filing
Aug 2, 2023
Next filing
Feb 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANNX Stock Option (Right to Buy) Award $0 +275K $0.00 275K Aug 1, 2023 Common Stock 275K $3.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from July 27, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.